Letko, Brosseau & Associates’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$96K Buy
45,950
+21,150
+85% +$44.2K ﹤0.01% 92
2025
Q1
$42.3K Buy
+24,800
New +$42.3K ﹤0.01% 87